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THINK PIECES 
NCDs 
Names, sums, and parts 
Clare Herrick 
Abstract  
The global burden of mortality and morbidity attributable to noncommunicable diseases 
(NCDs) now exceeds that of infectious disease. Yet, concern is mounting that global 
political prioritisation and action have stalled. The failure of NCDs to capture public and 
political imaginations has been ascribed to a number of reasons, with some recently 
contending that the very name of the disease classification is to blame. In this piece, I reflect 
critically on why discourse about NCDs has not compelled global action proportionate to 
the magnitude of the suffering these diseases cause. Failure to act on NCDs, I argue, is not a 
failure of terminology alone.   
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Though the term ‘noncommunicable diseases’ (NCDs) is ubiquitous in public health, it 
remains an unfamiliar construct to almost everyone else. This is common-sense enough: 
laypeople understand and experience diseases, such as diabetes or cancer, not categories. In 
effect, they experience and encounter the parts of the NCD category, never the sum. Yet, 
despite the absence of the term in everyday parlance, NCDs remain central to the language, 
tools, policy, and advocacy strategies of global and national public health. Indeed, and as 
medical researchers Blundell and Hine (2018, 5) have recently argued, although NCDs are 
‘well known to medical professionals, the jargonistic nature of the NCD acronym has not 
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caught the imagination of the world at large. . . . It has not become common enough to be 
featured and understood in the mass media’. This disjuncture between public health ubiquity 
and lay absence generates the question that animates this think piece: how to generate much-
needed political action on NCDs when popular awareness and understanding of the term 
remain so low? 
NCDs cause over 70 per cent of global mortality and 85 per cent of premature deaths in 
low- and middle-income countries (WHO 2017). The acronym is short for a nosological 
category comprised of four diseases (cancer, cardiovascular disease, chronic respiratory 
disease, and diabetes) and four modifiable behavioural risk factors (tobacco, alcohol, diet, 
and physical activity), commonly known as the ‘4 by 4’. Mental health is sometimes (but not 
always) included within this category (WHO 2018). While the NCD category may now be 
constituted in relatively neat terms, it has not always been so. The circuitous journey to the 
current ‘4 by 4’, described here, offers crucial context to better understand why the NCD 
category is failing to deliver political action at a time when it is needed most. NCDs 
therefore represent a twofold ‘crisis’: one of magnitude in terms of their health and 
economic costs, and one of persistent inaction in the face of these costs. Though the 
magnitude of the crisis is well evidenced and generally agreed upon, this certainty rarely 
translates into adequate or appropriate political action.  
To explore the context of this twofold crisis, I draw on reports by international organisations 
– the World Health Organisation’s World Health Reports, key NCD publications, and the 
World Bank’s World Development Reports from 1990 onwards – to reflect upon the emergence 
of the NCD category itself. Briefly describing the conceptual, epidemiological, and 
etymological evolution of this term, I show that ‘NCD’ was inserted into a shifting global 
health landscape where it has been limited in its ability to mitigate and manage the twofold 
crisis. While some public health researchers have argued that the impotence of NCDs lies 
with the name itself (Allen and Feigl 2017a, 2017b), I argue that the lack of political 
prioritisation cannot be resolved simply by changing the terminology. Rather, inaction 
represents the failure of ‘NCDs’ to resonate with the public and to create the kinds of 
meanings, values, and sense of crisis that make people anxious enough to care and politicians 
accountable enough to act.  
Making jargon 
The contemporary history of the language of NCDs starts with the first ‘global burden of 
disease’ (GBD) study published in the World Bank’s 1993 World Development Report. This 
study divided afflictions into three groups: (I) communicable, perinatal, and maternal; (II) 
noncommunicable; and (III) injuries. This hugely important report was one of the earliest to 
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tie together the recursive relationship between economic development and health at 
individual, household, national, and global scales. It also highlighted that while progress had 
been made in reducing mortality from infectious disease, mortality rates from 
noncommunicable diseases were climbing. This was especially the case in regions of the 
world previously thought to be burdened by infectious diseases. But the report also made 
new geographies of NCD burden visible and, in so doing, tightly yoked together health and 
development agendas.  
The report’s significance was not, however, limited to questions of geography. One of the 
key epidemiological ideas put forward by the authors of the GBD was the ‘disability adjusted 
life year’ (DALY). In measuring the contribution of the three disease categories above to 
years of healthy life lost, DALYs illuminated the scale and scope of the NCD burden. The 
use of DALYs showed that, contrary to the received wisdom of the period, the burden of 
NCDs was greater than that of communicable diseases in all regions except for sub-Saharan 
Africa, India, and the Middle East. The report also predicted that as mortality rates from 
communicable diseases declined, the population aged, and fertility rates fell, ‘the burden 
from noncommunicable diseases [would] increase sharply, both absolutely and 
proportionately’ (World Bank 1993, 32). This prediction of increasing morbidity and 
mortality as well as future increases in risk factors cemented a sense of impending public 
health crisis.  
The 1995 World Health Report (WHR) expanded on the nature of this crisis, arguing that 
‘developing countries will increasingly face the double burden of continuing to cope with a 
legacy of the traditional diseases of poverty, while dealing with a growing number of lifestyle 
diseases’ (WHO 1995, 32; emphasis added). The 1997 WHR (WHO 1997, 2) continued this 
theme, suggesting that NCDs were characteristic of a later stage of development trajectories, 
citing a ‘changing pattern of health in which poor countries inherit the problems of the rich, 
including not merely illness but also the harmful effects of alcohol, tobacco and drug use, 
and of injuries, suicide and violence’. This framing of NCDs as part of an inexorable 
development trajectory solidified the category’s identity as relating to the negative 
externalities of globalisation. It also firmly positioned NCDs as an important problem in, of, 
and for development.  
It is noteworthy that, at that time, NCDs were not yet referred to by their acronym and were 
defined by what they are not, rather than by what they are. The category began as a 
repository for the diseases that did not readily fit the other classifications. For example, after 
defining Group I as ‘infectious diseases and maternal and perinatal causes’, the WDR’s 
(1993, 197) annex states that ‘noncommunicable diseases include all other causes of death’ 
(emphasis added). In essence, therefore, it was a residual category whose members could be 
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combined; taken together, NCDs represented very high levels of disease burden. And yet, 
although the composition of the category managed to create and convey the magnitude of 
crisis – especially among low- and middle-income countries – the inconsistent adoption of 
the terminology used to describe it arguably diluted the messaging. Moreover, the lack of a 
commonly understood name for the problem did little to secure the political will to act.  
The WHO and World Bank reports from the mid-1990s continued to oscillate between the 
use of ‘chronic’ and ‘noncommunicable’ disease. In 1997, the WHR expanded its 
terminology, referring to ‘non-infectious chronic disease’ or the ‘chronic diseases which 
strike later in life’ (WHO 1997, 2). The lexical inconsistency continued well into the 2000s: 
the WHO’s 2004 Global Strategy on Diet, Physical Activity and Health used the term 
‘noncommunicable diseases’, while the NCD Action Plan 2008–2013 used the acronym. All 
the while, other documents still referred to ‘chronic disease’, as many still continue to do. 
Bernell and Howard (2016), for example, point out that the Centers for Disease Control use 
the term ‘chronic disease’ in relation to diseases in the United States, but use the term 
‘NCDs’ in their global health work, despite dealing with many of the same diseases. But by 
2011, when the first UN High Level Meeting (UN HLM) was held, the acronym was in 
common use by international organisations. The widespread adoption of the term was likely 
aided by the 2009 formation of the NCD Alliance, an influential lobbying and advocacy 
group that was instrumental in driving forward the case for the ‘urgency’ of the global NCD 
burden and, therefore, the need for the UN HLM. 
While the terminology might have been inconsistently deployed, it is notable that the term 
‘NCD’ was never actively problematised in any of the reports I have cited. Rather, concern 
coalesced around the problem that, as the WHO (1997, 3) argued, ‘separating infectious and 
chronic diseases creates something of a false division. It is becoming more and more difficult 
to establish a firm borderline between them’. As biomedical research has shown, the risk 
factors for NCDs are innately fluid and cross-cut infectious agents, behavioural risk factors, 
and manifold life conditions. Medical historian McKeown (2009, 7) notes that ‘not only is it 
the case that some infectious diseases have chronic disease characteristics, but we have come 
to recognize the importance of infectious agents and related inflammatory processes in the 
aetiology of a number of chronic diseases and adverse outcomes’ (see also Seeberg and 
Meinert 2015).  
The inclusion of NCDs within the United Nations’ Sustainable Development Goals (SDGs) 
in 2015 produced high hopes for swift and effective political action and global health 
funding. While the NCD agenda has enjoyed clear progress in the form of SDG targets and 
indicators, this has yet to really dent the upward trends in NCD prevalence, especially across 
the global South. Funding levels also remain a fraction of those granted to the global health 
behemoths of malaria, HIV/AIDS, and tuberculosis. In 2013, for example, NCDs 
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commanded only 1.3 per cent of all Development Assistance for Health funding (Nugent 
2016). These funding gaps are inseparable from the ‘malignant neglect’ of NCDs within 
global health prioritisation (Stuckler and Basu 2013). However, it is significant that recent 
debate in the Lancet sidesteps this economic reality in favour of ascribing inaction to the 
terminology alone. I want to briefly turn to this debate in order to explore why names alone 
are less significant than their deployment and popular use.  
On names and naming 
Over the last decade there was great hope within the public health community that the UN 
High Level Meetings in 2011, 2014, and 2018 might catalyse much-needed multisectoral 
action on NCDs. For public health advocates, the 2011 HLM was an unparalleled 
‘opportunity to stimulate a coordinated global response to NCDs that is commensurate with 
their health and economic burdens’ (Beaglehole et al. 2011, 449). Yet, since the 2011 Political 
Declaration of the United Nations General Assembly on the Prevention and Control of 
NCDs, hope has been replaced by feelings of panic that the momentum behind the cause is 
waning (Horton and Sargent 2018). Lurking behind the politics of political prioritisation is 
the unresolved question of whether NCDs do not readily lend themselves to the kind of 
stories that ignite public passion and political action because of a fundamental problem of 
their nomenclature. This debate starts from the supposition that the current name is not 
working, evidenced by the fact that progress is slow, governments are not sufficiently 
committed and not meeting their own voluntary targets, funding has not materialised, and 
the forces of ‘vested interests’ are too strong.  
Along these lines, public health researchers Allen and Feigl (2017b, e129) invite public health 
researchers to reflect on ‘what’s in a name’, arguing that the ‘branding’ of NCDs is 
underdeveloped and the disease classifications themselves are ‘both outdated and 
counterproductive’. The authors assert that the word ‘“noncommunicable” propagates 
confusion, undermines efforts to spur a sense of urgency and deflects attention from 
effective systems-wide interventions’ in favour of a continued focus on individual 
behavioural modification (Allen and Feigl 2017b, e129). They propose renaming NCDs as 
‘socially transmitted conditions’ to shift attention and action to their upstream commercial 
and socioeconomic determinants, and away from individuals and their risk behaviours (Allen 
and Feigl 2017a). The term ‘socially transmitted’, they argue, is ‘vastly more transparent, 
accurate and tractable’ and offers a ‘coherent and internationally significant narrative’ (Allen 
and Feigl 2017a, e645).  
In response to their paper, researchers have suggested numerous other terms to replace 
NCDs. These include ‘industriogenic diseases’ (Lincoln 2017), ‘lifelong diseases’ (Rigby 
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2017), ‘interactional diseases’ (Kozelka and Jenkins 2017), ‘human-made illness’ (Blundell 
and Hine 2018), and ‘biosocial and development diseases’ (Zou et al. 2017). Two online polls 
on the topic provide additional suggestions, including ‘avoidable behavioural and chronic 
diseases’, ‘the major diseases’, ‘proximal disorders’, ‘blue and green diseases’, 
‘cardiometabolic diseases’, and, my favourite, ‘insidious killer diseases’. Intended to replace a 
vague and obtuse acronym, these terms are arguably even more vague and obtuse than 
‘NCDs’. ‘Socially transmitted’, ‘interactional’, ‘biosocial’, and ‘industriogenic’, for example, 
are terms whose meaning even health researchers cannot agree on. More importantly, they 
are utterly meaningless to a lay audience. It reminds me of when I asked a friend to read my 
PhD thesis, and they thought I’d made most of the words up. While I thought these ‘made-
up’ words were powerful and resonant, my friend thought they were nonsensical. For 
NCDs, political action is not hindered because the term is inaccurate, but because it has not 
been infused with enough common meaning, power, significance, and resonance to compel 
change. What I find remarkable in these critiques is the assertion that institutional failures to 
mount effective responses can be traced to the label of NCDs, as if with a change of 
terminology alone – rather than with a fundamental shift in global political economy, a turn 
to global social justice, and the reduction in the power of lobbyists – apathy will be 
transformed into action. 
So what? 
Tackling NCDs in meaningful, effective, and equitable ways goes far beyond words alone. 
As George Alleyne and colleagues (2011) have argued, NCDs need to incite more fear to 
galvanise action. The history of public health clearly bears out this argument, with ‘public 
hysteria’ about infectious disease outbreaks far outstripping any ‘public fear’ of the dangers 
posed by NCDs (Alleyne, Basu, and Stuckler 2011, 84). This lack of ‘public angst’ or 
‘international hysteria’ is important because it means that NCDs have effectively become 
normalised and routine. Deaths from NCDs are tragic and often premature, but they are not 
cast with the same tenor of panic that accompany infectious diseases. Interestingly, among 
the alternative terms mooted in the Lancet debate, none would seem to incite fear or hysteria 
any more than ‘NCDs’. Rather, each term emerges from a different problem frame and 
requires a slightly different locus of action and set of solutions. However, and crucially, none 
of these are immediately obvious to anyone other than health researchers.  
What then of the NCD term itself? If NCDs have thus far failed to ignite any sense of 
urgency, then perhaps it is because the term has yet to be infused with meanings sufficient to 
generate the right sense of ‘crisis’. And even though the metrics of NCDs may convey crisis, 
this is not translated into any particular sense of crisis. The problem is not so much that the 
name is deficient, but that it is not in common parlance and has no resonance with the 
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public. This is not a failure of terminology alone, but a broader failure to connect that 
terminology to the lives and experiences of laypeople in a meaningful way. When people go 
to the doctor, they get diagnosed with a disease or diseases, not an NCD. For NCDs then, 
the power of the sum – regardless of the name – is arguably far less than that of its 
commonly understood parts. This raises an obvious question ignored in the debate on 
naming: if individual diseases already have powerful names, frames, and ‘brands’ that 
resonate and draw in research and advocacy money, how can the sum of these parts be 
infused with the power and resonance to catalyse change? A first step might be that if people 
in health care settings talked instead of NCDs (rather than individual diseases) and risk 
factors were linked to NCDs in the media, then the public might start to recognize the term.  
Debates that happen in a public health vacuum will not alter the average person’s 
experiences of health and illness. But when terms are mainstreamed into popular use and 
people identify with them and start to identify the broader issues they raise – of social 
justice, inequality, poverty, political economic systems, industry lobbying, regulation, and 
social protection – then they might begin to care. And when people start to care, then they 
will demand change. It is then far more likely that political mobilisation and action will 
follow. Inspiring care is often about finding the right words, but people must first know that 
those words exist and what they really mean.   
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